AI Engines For more Details: Perplexity Kagi Labs You
Muscle Relaxation: Methocarbamol works by acting on the central nervous system to inhibit nerve impulses or pain sensations that cause muscle spasms or stiffness. It helps relax muscles, relieving discomfort and improving mobility.
Musculoskeletal Conditions: Methocarbamol is commonly prescribed for the symptomatic relief of acute musculoskeletal conditions, such as muscle strains, sprains, and injuries. It can alleviate muscle pain, stiffness, and tension associated with these conditions.
Pain Relief: In addition to its muscle relaxant properties, methocarbamol may provide analgesic (pain-relieving) effects by reducing muscle spasm-induced pain. It can help improve the overall pain threshold in individuals with musculoskeletal discomfort.
Short-Term Use: Methocarbamol is typically used for short-term management of acute muscle-related symptoms. It is often prescribed along with rest, physical therapy, and other supportive measures to facilitate recovery from musculoskeletal injuries or conditions.
Safety Profile: Methocarbamol is generally considered safe when used as directed. However, like all medications, it may cause side effects in some individuals. Common side effects may include drowsiness, dizziness, lightheadedness, nausea, headache, and blurred vision.
Central Nervous System Effects: Methocarbamol can cause central nervous system (CNS) depression, especially when taken in higher doses or in combination with other CNS depressants such as alcohol or sedatives. Patients should avoid activities requiring mental alertness or coordination, such as driving, until they know how methocarbamol affects them.
Allergic Reactions: While rare, some individuals may experience allergic reactions to methocarbamol, characterized by symptoms such as rash, itching, swelling, dizziness, difficulty breathing, or chest tightness. Anyone experiencing signs of an allergic reaction should seek medical attention promptly.
Drug Interactions: Methocarbamol may interact with other medications, including opioids, benzodiazepines, and certain antidepressants, potentially enhancing sedative effects or respiratory depression. Patients should inform their healthcare providers about all medications they are taking to avoid potential interactions.
Liver and Kidney Function: Methocarbamol is primarily metabolized by the liver and eliminated from the body through the kidneys. Patients with impaired liver or kidney function may require dose adjustments or close monitoring while taking methocarbamol.
Pregnancy and Lactation: The safety of methocarbamol use during pregnancy or breastfeeding has not been well studied. Pregnant or nursing women should consult their healthcare providers before using methocarbamol to weigh the potential benefits against potential risks to the fetus or infant.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Parabacteroides distasonis | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.2 | 0.2 | |
Acne | 0.2 | -0.2 | |
ADHD | 2.4 | 0.2 | 11 |
Age-Related Macular Degeneration and Glaucoma | 0.2 | 0.1 | 1 |
Allergic Rhinitis (Hay Fever) | 1 | 2.1 | -1.1 |
Allergies | 3.7 | 1.9 | 0.95 |
Allergy to milk products | 1.5 | 0.9 | 0.67 |
Alopecia (Hair Loss) | 0.6 | 0.6 | |
Alzheimer's disease | 2.9 | 3 | -0.03 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.4 | 1.1 | 1.18 |
Ankylosing spondylitis | 2.6 | 0.6 | 3.33 |
Anorexia Nervosa | 0.7 | 1.2 | -0.71 |
Antiphospholipid syndrome (APS) | 0.8 | 0.8 | |
Asthma | 2.6 | 2.1 | 0.24 |
Atherosclerosis | 1.1 | 0.9 | 0.22 |
Atrial fibrillation | 1.5 | 1 | 0.5 |
Autism | 3.9 | 5.3 | -0.36 |
Autoimmune Disease | 0.7 | 0.4 | 0.75 |
Barrett esophagus cancer | 0.2 | 0.1 | 1 |
benign prostatic hyperplasia | 0.4 | 0.2 | 1 |
Biofilm | 0.8 | 0.8 | |
Bipolar Disorder | 0.8 | 0.6 | 0.33 |
Brain Trauma | 0.4 | 0.7 | -0.75 |
Breast Cancer | 0.5 | 0.5 | |
Cancer (General) | 0.4 | 1.2 | -2 |
Carcinoma | 1.5 | 1.1 | 0.36 |
Celiac Disease | 1.5 | 2.3 | -0.53 |
Cerebral Palsy | 0.9 | 0.6 | 0.5 |
Chronic Fatigue Syndrome | 2.6 | 2.5 | 0.04 |
Chronic Kidney Disease | 1.8 | 1.2 | 0.5 |
Chronic Lyme | 0.5 | 0.4 | 0.25 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.9 | 0.8 | 0.13 |
Chronic Urticaria (Hives) | 0.9 | 0.5 | 0.8 |
Coagulation / Micro clot triggering bacteria | 1 | 0.5 | 1 |
Cognitive Function | 0.8 | 0.7 | 0.14 |
Colorectal Cancer | 2.8 | 1.2 | 1.33 |
Constipation | 1 | 0.3 | 2.33 |
Coronary artery disease | 1.1 | 1.1 | 0 |
COVID-19 | 5.4 | 5.6 | -0.04 |
Crohn's Disease | 3.3 | 3.2 | 0.03 |
Cushing's Syndrome (hypercortisolism) | 0.2 | -0.2 | |
cystic fibrosis | 0.7 | 1.2 | -0.71 |
d-lactic acidosis (one form of brain fog) | 0.5 | 0.5 | |
deep vein thrombosis | 1.2 | 0.5 | 1.4 |
Denture Wearers Oral Shifts | 0.4 | 0.4 | |
Depression | 5.1 | 5 | 0.02 |
Dermatomyositis | 0.1 | 0.2 | -1 |
Eczema | 0.6 | 0.7 | -0.17 |
Endometriosis | 1.8 | 1.5 | 0.2 |
Eosinophilic Esophagitis | 0.2 | -0.2 | |
Epilepsy | 1.8 | 1.5 | 0.2 |
erectile dysfunction | 0.6 | 0.2 | 2 |
Fibromyalgia | 1.1 | 0.7 | 0.57 |
Functional constipation / chronic idiopathic constipation | 3.4 | 1.3 | 1.62 |
gallstone disease (gsd) | 1.3 | 0.7 | 0.86 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.2 | 0.8 | -3 |
Generalized anxiety disorder | 1.7 | 1.4 | 0.21 |
giant cell arteritis | 0 | 0 | |
Glioblastoma | 0.1 | -0.1 | |
Gout | 1.3 | 0.5 | 1.6 |
Graves' disease | 0.9 | 1.2 | -0.33 |
Gulf War Syndrome | 0.3 | 1.2 | -3 |
Halitosis | 0.4 | 0.1 | 3 |
Hashimoto's thyroiditis | 1.4 | 1.1 | 0.27 |
Heart Failure | 2.5 | 0.9 | 1.78 |
hemorrhagic stroke | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 0.5 | 0.2 | 1.5 |
High Histamine/low DAO | 0.6 | 0.3 | 1 |
hypercholesterolemia (High Cholesterol) | 0.7 | 0.5 | 0.4 |
hyperglycemia | 1.3 | 1.5 | -0.15 |
Hyperlipidemia (High Blood Fats) | 0.6 | 0.1 | 5 |
hypersomnia | 0.3 | -0.3 | |
hypertension (High Blood Pressure | 2.5 | 3.7 | -0.48 |
Hypothyroidism | 0.3 | 0.6 | -1 |
Hypoxia | 0.9 | 0.9 | |
IgA nephropathy (IgAN) | 0.5 | 2.5 | -4 |
Inflammatory Bowel Disease | 4.6 | 5 | -0.09 |
Insomnia | 0.8 | 2.1 | -1.63 |
Intelligence | 0.9 | 0.9 | |
Intracranial aneurysms | 0.6 | 0.2 | 2 |
Irritable Bowel Syndrome | 3.7 | 3 | 0.23 |
ischemic stroke | 2 | 0.7 | 1.86 |
Liver Cirrhosis | 3.5 | 2.4 | 0.46 |
Long COVID | 3.2 | 4.4 | -0.38 |
Low bone mineral density | 0.6 | -0.6 | |
Lung Cancer | 0.5 | 0.8 | -0.6 |
Lymphoma | 0.4 | 0.4 | |
Mast Cell Issues / mastitis | 0.4 | 0.4 | 0 |
ME/CFS with IBS | 0.4 | 1.2 | -2 |
ME/CFS without IBS | 0.2 | 0.9 | -3.5 |
membranous nephropathy | 0.1 | 0.1 | |
Menopause | 1.8 | 0.4 | 3.5 |
Metabolic Syndrome | 2.9 | 4 | -0.38 |
Mood Disorders | 5.4 | 4.1 | 0.32 |
multiple chemical sensitivity [MCS] | 0.5 | 0.2 | 1.5 |
Multiple Sclerosis | 2.8 | 2.2 | 0.27 |
Multiple system atrophy (MSA) | 1.5 | 0.5 | 2 |
myasthenia gravis | 0.4 | 0.2 | 1 |
neuropathic pain | 0.1 | 2.2 | -21 |
Neuropathy (all types) | 0.5 | 0.9 | -0.8 |
neuropsychiatric disorders (PANDAS, PANS) | 0.7 | 0.7 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3 | 3.6 | -0.2 |
NonCeliac Gluten Sensitivity | 1.3 | 0.4 | 2.25 |
Obesity | 5.4 | 3.4 | 0.59 |
obsessive-compulsive disorder | 3.3 | 1.6 | 1.06 |
Osteoarthritis | 0.9 | 0.8 | 0.13 |
Osteoporosis | 1.1 | 1.1 | 0 |
pancreatic cancer | 0.3 | 0.1 | 2 |
Parkinson's Disease | 4.2 | 2.3 | 0.83 |
Polycystic ovary syndrome | 2.3 | 1.5 | 0.53 |
Postural orthostatic tachycardia syndrome | 0 | 0.4 | 0 |
Premenstrual dysphoric disorder | 0.5 | 0.1 | 4 |
primary biliary cholangitis | 0.3 | 0.2 | 0.5 |
Primary sclerosing cholangitis | 1.2 | 1.2 | 0 |
Psoriasis | 1.7 | 1.4 | 0.21 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3.2 | 1.4 | 1.29 |
Rosacea | 0.4 | 0.2 | 1 |
Schizophrenia | 3.7 | 1.9 | 0.95 |
scoliosis | 0.6 | 0.7 | -0.17 |
Sjögren syndrome | 1.5 | 1.2 | 0.25 |
Sleep Apnea | 0.8 | 0.7 | 0.14 |
Slow gastric motility / Gastroparesis | 0.9 | 0.2 | 3.5 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1 | 0.5 | 1 |
Stress / posttraumatic stress disorder | 1.6 | 1.6 | 0 |
Systemic Lupus Erythematosus | 1.5 | 1.3 | 0.15 |
Tic Disorder | 0.3 | 0.4 | -0.33 |
Tourette syndrome | 0.3 | 0.2 | 0.5 |
Type 1 Diabetes | 2.4 | 2.1 | 0.14 |
Type 2 Diabetes | 3.3 | 3.4 | -0.03 |
Ulcerative colitis | 2.4 | 3.8 | -0.58 |
Unhealthy Ageing | 1.5 | 1.2 | 0.25 |
Vitiligo | 1 | 1 | 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]